Zobrazeno 1 - 1
of 1
pro vyhledávání: '"M Gorgas-Torner"'
4CPS-019 Alirocumab and evolocumab: effectiveness after 3 years of follow-up in a real world setting
Autor:
M Gomez-Domingo, C Alonso Martinez, Silvia García-García, I Cardona-Pascual, M Larrosa-Garcia, M Gorgas-Torner, C Alerany Pardo, J Vidal-Otero, M Miarons-Font, P Sanchez-Sanchez
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Hypercholesterolaemia leads to a higher risk of atherosclerosis and cardiovascular events. Familial hypercholesterolaemia is more resistant to usual treatments. In 2015, the PCSK9 inhibitors (PCSK9I) alirocumab and evolocuma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46b4f72f7924652a1a2d7c3eb73d0f14
https://doi.org/10.1136/ejhpharm-2020-eahpconf.120
https://doi.org/10.1136/ejhpharm-2020-eahpconf.120
